Three of America’s largest hospital networks are accusing CVS Health of quietly pocketing hundreds of millions in prescription drug savings that should have gone to patients and healthcare providers, according to a lawsuit that exposes how middlemen profit from the chaos in drug pricing.
Northwell Health, Allegheny Health Network, and ChristianaCare filed the complaint in federal court, alleging that CVS Caremark — the pharmacy benefit manager arm of CVS — manipulated the 340B Drug Pricing Program to enrich itself at the expense of hospitals serving low-income communities. The 340B program, created by Congress in 1992, requires drug manufacturers to offer steep discounts to qualifying hospitals and clinics that treat large numbers of poor and uninsured patients.
The lawsuit claims CVS secretly recaptured those mandated discounts through a web of hidden fees and payment adjustments, effectively clawing back savings meant to help hospitals provide care to vulnerable populations. The hospitals say this scheme has cost them hundreds of millions of dollars over several years — money that would have funded cancer treatments, diabetes care, and other services for patients who can least afford them.
Pharmacy benefit managers like CVS Caremark sit between drug manufacturers, insurance companies, and pharmacies, negotiating prices and deciding which medications get covered. They’ve grown into powerful corporate giants operating in the shadows of healthcare, with little transparency about how they make money or set the prices patients pay at the counter.
The timing puts fresh pressure on CVS, which already faces scrutiny over its growing control of multiple parts of the healthcare system. The company owns not only the PBM operation but also the CVS pharmacy chain, the Aetna insurance business, and a network of walk-in clinics. Critics say this vertical integration creates conflicts of interest and allows CVS to profit at every step while patients struggle with high drug costs.
The three hospital systems represent major healthcare providers across the Northeast and Mid-Atlantic, serving millions of Americans. Northwell Health operates New York’s largest healthcare network. If they prevail in court, the case could force changes in how PBMs operate and potentially free up significant funding for safety-net hospitals nationwide.
CVS did not immediately respond to requests for comment on the allegations. The lawsuit seeks to recover the allegedly diverted funds plus additional damages. The case will test whether federal courts are willing to crack down on PBM practices that have largely escaped regulatory oversight despite bipartisan concern in Congress about their role in rising prescription costs.
Key Points
- Northwell Health, Allegheny Health Network, and ChristianaCare sued CVS for allegedly diverting hundreds of millions in drug savings from the 340B program designed to help hospitals serve poor patients
- The lawsuit claims CVS Caremark manipulated discount programs through hidden fees to recapture savings that should have funded care for vulnerable populations
- The case highlights growing concerns about pharmacy benefit managers operating with little transparency while controlling drug prices at multiple points in the healthcare system
https://www.foxbusiness.com/markets/three-major-hospital-systems-accuse-cvs-secretly-siphoning-hundreds-millions-drug-savings – May 21, 2026
